Madrid, Spain

Jose Ignacio Andres Gil

USPTO Granted Patents = 12 


 

Average Co-Inventor Count = 9.7

ph-index = 4

Forward Citations = 57(Granted Patents)


Company Filing History:


Years Active: 2015-2025

Loading Chart...
Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: Jose Ignacio Andres Gil: Innovator in Pharmaceutical Compounds

Introduction

Jose Ignacio Andres Gil is a prominent inventor based in Madrid, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that modulate the P2X7 receptor. With a total of 12 patents to his name, his work has the potential to impact various therapeutic areas.

Latest Patents

Among his latest patents, Jose has developed P2X7 modulators, which are directed to compounds of Formula (I). These compounds include enantiomers and diastereomers, and the invention also encompasses pharmaceutical compositions comprising these compounds. Additionally, he has worked on another set of P2X7 modulators, which are directed to compounds of Formulas (I, IIa, and IIb). This invention also relates to pharmaceutical compositions and methods of making and using these compounds.

Career Highlights

Jose Ignacio Andres Gil is currently associated with Janssen Pharmaceutica NV, where he continues to innovate in the pharmaceutical sector. His expertise in developing novel compounds has positioned him as a key player in the industry.

Collaborations

Jose has collaborated with notable colleagues, including Michael Anthony Letavic and Manuel Jesus Alcazar Vaca. These partnerships have further enhanced his research and development efforts.

Conclusion

Jose Ignacio Andres Gil is a distinguished inventor whose work in pharmaceutical compounds is paving the way for new therapeutic options. His contributions to the field are noteworthy and continue to influence the landscape of medical innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…